India’s rare disease care relies on crowdfunding as costly therapies outstrip public support. Government aid is capped and ...
A preliminary investigation by the Chongqing Municipal Health Commission has found that a doctor at the Chongqing Medical ...
Comedian Samay Raina found himself in the unfamiliar halls of the Supreme Court instead of a comedy club for making remarks, ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
Loss of muscle mass, also called muscle wasting or atrophy, can happen gradually as part of getting older or more suddenly ...
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in. On December 8, Novartis AG (NYSE:NVS) was upgraded to ...
SMA gene therapy Zolgensma safely improved motor function in children with SMA who needed tracheostomy, a real-world study ...
The effects allowed these minors who could sit but not stand to move like they've never done before, including walking and ...
Notably, Novartis AG (NYSE:NVS)’s operating income came in at US$4.5 billion, up by 24% (27% in constant currency), thanks to ...
Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal ...
A single-dose gene replacement therapy is found to improve movement ability in children over 2 years of age and teenagers with spinal muscular atrophy, according to research published in Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback